Track topics on Twitter Track topics that are important to you
US drug development specialist Catalent Pharma Solutions and Valerius Biopharma, a Swiss biopharmaceutical company providing interchangeable treatment options for high-priced orphan and non-orphan biologics, have announced plans to collaborate on the development and manufacture of Valerius’ biosimilar products.
Original Article: Catalent and Valerius Link on BiosimilarsNEXT ARTICLE
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...